1-4 of 4
Jamie Chin
Close
Sort by
Journal Articles

Assessing the Safety of Discharging Patients Receiving High-Dose Methotrexate with Levels Greater Than 0.1 Umol/L

Elaine Xiang, Jamie Chin, Jonathan Weltz, Aaron Sango, Meredith Akerman, Michael L. Grossbard, Shella Saint Fleur-Lominy
Journal: Blood
Blood (2022) 140 (Supplement 1): 10806–10807.
https://doi.org/10.1182/blood-2022-167207
Published: 2022
Journal Articles

Evaluating the Safety of Outpatient Ramp up of Venetoclax in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Elaine Xiang, Frank Cirrone, Jamie Chin, Meredith Akerman, Shella Saint Fleur-Lominy, Maher Abdul Hay
Journal: Blood
Blood (2021) 138 (Supplement 1): 2311.
https://doi.org/10.1182/blood-2021-145057
Published: 2021
Journal Articles

Efficacy and Safety of Direct Oral Anticoagulants in Extremes Weights

Julie Huang, DO, Jamie Chin, PharmD, Alexander Hindenburg, MD, Lilia Davenport, PharmD, Debra Willner, PharmD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-137150
Published: 2020
Journal Articles

Comparative Use of Direct Oral Anticoagulants and Warfarin in the Treatment of Atrial Fibrillation and Venous Thromboembolism and Prophylaxis: A Retrospective Single Center Utilization Study

Linda Hoang, MD, Josephine Pineda Dela Cruz, MD, Stephen Farley, PharmD, Julia Sessa, PharmD, Jamie Chin, PharmD, Rose Calixte, PhD, Alexander Hindenburg, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3367.
https://doi.org/10.1182/blood.V130.Suppl_1.3367.3367
Published: 2017